Sriskandarajah, P., De Haven Brandon, A., MacLeod, K., Carragher, N. O., Kirkin, V., Kaiser, M., & Whittaker, S. R. (2020). Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma. BMC Cancer.
Citação norma ChicagoSriskandarajah, Priya, Alexis De Haven Brandon, Kenneth MacLeod, Neil O. Carragher, Vladimir Kirkin, Martin Kaiser, and Steven R. Whittaker. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.
Citação norma MLASriskandarajah, Priya, et al. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.